Ian A. Blair

faculty photo
A.N. Richards Professor of Pharmacology
Director, Center for Cancer Pharmacology, University of Pennsylvania School of Medicine
Investigator, Abramson Cancer Center, University of Pennsylvania School of Medicine
Member, Institute for Medicine and Engineering, University of Pennsylvania School of Medicine
Investigator, Genomics Institute, University of Pennsylvania School of Medicine
Scientific Director, Proteomics Core Laboratory, Genomics Institute and Abramson Cancer Center, University of Pennsylvania School of Medicine
Vice Chair, Department of Pharmacology, University of Pennsylvania School of Medicine
Scientific Director, Mass Spectrometry Facility, Department of Chemistry, University of Pennsylvania
Director, Program in Systems Biology, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Member, Institute for Translational Medicine and Therapeutics, University of Pennsylvania School of Medicine
Department: Pharmacology

Contact information
854 Biomedical Research Building II/III
University of Pennsylvania School of Medicine
Center for Cancer Pharmacology
421 Curie Boulevard
Philadelphia, PA 19104-6160
Office: (215) 573-9880
Fax: (215) 573-9889
Graduate Group Affiliations
Education:

Cambridge Grammar School for Boys, United Kingdom , 1960.

Prince of Wales School, Nairobi, Kenya, 1963.
B.Sc. ((Special) Chemistry, ARCS)
Imperial College of Science and Technology, University of London, United Kingdom, 1968.
Ph.D.
Imperial College of Science and Technology, University of London, United Kingdom, 1971.
MRSC (Organic Chemistry)
Adelaide University, Australia, 1972.
ARACI
Australian National University, 1977.
Permanent link
 

Description of Research Expertise

Oxidative stress, carcinogenesis, cardiovascular disease, and neurodegenerative disease
Oxidative stress results in damage to lipids through the formation of lipid hydroperoxides. Our laboratory is involved in determining the factors that control lipid hydroperoxide-mediated damage to DNA, and proteins. We are also characterizing the lesions in these macromolecules using novel mass spectrometry methodology, determining how the lesions affect proliferation and apoptosis using model in vitro systems, and assessing how such processes can be prevented using novel pharmacological agents. We also have a program in biomarker discovery and analysis, which is focused on metabolomic and proteomic biomarkers of smoking, pancreatic cancer, breast cancer, and neurodegenerative diseases. This involves the use of quantitative stable isotope dilution liquid chromatography-mass spectrometry methodology. We recently implement the use of stable isotope dilution by essential nutrients in cell culture (SILEC) as a method for analyzing important Krebs cycle coenzyme A-thioesters. This has made it possible to examine the effects of chemicals and disease on mitochondrial dysfunction.

Description of Itmat Expertise

Dr. Blair is interested in oxidative stress in cancer, cardiovascular disease, and neurodegenerative disease including the investigation of the role of endogenous DNA- and glutathione-adducts as biomarkers of cancer and cardiovascular disease in vitro, in animal models and humans. He is also developing metabolomic biomarkers of neurodegenerative diseases in humans and in animal models.

Selected Publications

Hood ED, Greineder CF, Dodia C, Han J, Mesaros C, Shuvaev VV, Blair IA, Fisher AB, Muzykantov VR: Antioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo. J Control Release 163(2): 161-169, Oct 2012.

Hammons AL, Summers CM, Jochems J, Arora JS, Zhang S, Blair IA, Whitehead AS. : Pemetrexed alters folate phenotype and inflammatory profile in EA.hy 926 cells grown under low-folate conditions. Eur J Pharmacol Sept 2012.

MacDonald ML, Ciccimaro E, Prakash A, Banerjee A, Seeholzer SH, Blair IA, Hahn CG: Biochemical Fractionation and Stable Isotope Dilution Liquid Chromatography-Mass Spectrometry for Targeted and Microdomain-Specific Protein Quantification in Human Postmortem Brain Tissue. Mol Cell Proteomics Aug 2012.

Zhang L, Huang M, Blair IA, Penning TM: Detoxication of Benzo[a]pyrene-7,8-dione by Sulfotransferases (SULT) in Human Lung Cells. J. Biol. Chem 287(35): 29909-20, Jul 2012.

Ashare RL, Tang KZ, Mesaros AC, Blair IA, Leone FT, Strasser AA. (2012) : Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers. J Psychopharmacol June 2012.

Mesaros C, Arora JS, Wholer A, Vachani A, Blair IA : 8-Oxo-2'-deoxyguanosine as a biomarker of tobacco-smoking-induced oxidative stress. Free Radic Biol Med 53(3): 610-617, May 2012.

Mesaros C., Blair I.A. : Targeted Chiral Analysis of Bioactive Arachidonic Acid Metabolites Using Liquid-Chromatography-Mass Spectrometry. Metabolites 2(2): 337-365, 2012.

Huang M, Liu X, Basu SS, Zhang L, Kushman ME, Harvey RG, Blair IA, Penning TM.: Metabolism and Distribution of Benzo[a]pyrene-7,8-dione (B[a]P-7,8-dione) in Human Lung Cells by Liquid Chromatography Tandem Mass Spectrometry: Detection of an Adenine B[a]P-7,8-dione Adduct. Chem Res Toxicol. 25(5): 993-1003, 2012.

Gelhaus SL, Gilad O, Hwang W-T, Penning TM, Blair IA. : Multidrug Resistance Protein (MRP) 4 Attenuates Benzo[a]Pyrene-Mediated DNA-adduct Formation in Human Bronchoalveolar H358 Cells. Toxicol Lett 209(1): 58-66, 2012.

Basu SS and Blair IA: Labeling by Essential Nutrients in Cell Culture (SILEC): a protocol to generate and utilize isotopically labeled coenzyme A standards. Nature Protocols 7(1): 1-11, 2012.

back to top
Last updated: 10/24/2012
The Trustees of the University of Pennsylvania